Despite weak Q3 earnings, Bharat Petroleum (BPCL) draws attention from global brokerages. CLSA upgraded BPCL to ‘Hold’ with a ...

Healthcare stocks see mixed performance as Dr Lal Pathlabs and Aurobindo Pharma rise over 2% after CLSA upgrades their ...

The firm expects mid-single-digit price erosion in generic drugs and heightened competition for key medications, potentially ...

Shares of UltraTech Cement Ltd. fell on Friday despite the third quarter numbers being slightly ahead of expectations.

This steady growth in HDFC Bank's core earnings - both NII and net profit - came in despite a marginal rise in NPAs and NPA ...

Brokerage firm Nuvama has highlighted concerns about BPCL's weak refining margin environment and LPG under-recoveries, which ...

CLSA reaffirmed Bharti Airtel as Indias top telecom pick, citing robust growth potential and 5G expansion. Indus Towers, Tata Communications, and others also received mixed ratings, while Vodafone ...

2025 Market Outlook: CLSA anticipates a challenging year for the Nifty in 2025, driven by an uncertain and risky global macro environment coupled with a near-term economic slowdown in India.

CLSA has initiated coverage on Hyundai Motor India with an 'Outperform' rating and a target price of Rs 2,155, citing strong ...

Shares of most staples companies in India, from HUL, to Nestle India to ITC, or even Avenue Supermarts, have corrected between 20% to 30% from their peak so far.

Finance companies' performance in the first half of 2025 is expected to be impacted by high credit costs due to unsecured credit. But it is seen normalising in the second half on underwriting ...